Sophia Genetics (SOPH) said Tuesday it has started a proposed underwritten public offering of its shares.

The company said it expects to give underwriters an option to buy up to an additional 15% of the shares.

The offering is subject to market and other conditions, the company said.

The company's shares were down 5.7% in after-hours activity.